Cytotoxics (Oncology Drug Substances) Market Report

China Cytotoxics (Oncology Drug Substances) Industry Market Research Report 2023-2029

  • POSTDATE：Sep 18, 2023
  • PAGES：222
  • REPORT CODE：GMM1808382
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Cytotoxics (Oncology Drug Substances) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • F Hoffmann-La Roche AG

    • Johnson & Johnson

    • Pfizer Inc

    • GlaxoSmithKline plc

    • AbbVie, Inc

    • Novartis AG

    • Sanofi

    • Baxter

    • Merck & Co Inc

    By Type:

    • Intravenous

    • Oral

    By Application:

    • Prostate Cancer

    • Other

    • Pancreatic Cancer

    • Breast Cancer

    • Lung Cancer

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Cytotoxics (Oncology Drug Substances) Market Overview 2018-2029

    • 1.1 China Cytotoxics (Oncology Drug Substances) Industry Development Overview

    • 1.2 China Cytotoxics (Oncology Drug Substances) Industry Development History

    • 1.3 China Cytotoxics (Oncology Drug Substances) Industry Market Size (2018-2029)

    • 1.4 China Cytotoxics (Oncology Drug Substances) Market Analysis by Type from Production Side

      • 1.4.1 China Cytotoxics (Oncology Drug Substances) Production Volume, Production Value and Growth Rate of Intravenous (2018-2029)

      • 1.4.2 China Cytotoxics (Oncology Drug Substances) Production Volume, Production Value and Growth Rate of Oral (2018-2029)

    • 1.5 China Cytotoxics (Oncology Drug Substances) Market Analysis by Application from Consumption End

      • 1.5.1 China Cytotoxics (Oncology Drug Substances) Sales Volume, Sales Value and Growth Rate of Prostate Cancer (2018-2029)

      • 1.5.2 China Cytotoxics (Oncology Drug Substances) Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.3 China Cytotoxics (Oncology Drug Substances) Sales Volume, Sales Value and Growth Rate of Pancreatic Cancer (2018-2029)

      • 1.5.4 China Cytotoxics (Oncology Drug Substances) Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

      • 1.5.5 China Cytotoxics (Oncology Drug Substances) Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

    • 1.6 China Cytotoxics (Oncology Drug Substances) Market Analysis by Region

      • 1.6.1 North China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Cytotoxics (Oncology Drug Substances) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Cytotoxics (Oncology Drug Substances) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Cytotoxics (Oncology Drug Substances) Market Status and Competition Analysis in 2023

      • 2.2.3 China Cytotoxics (Oncology Drug Substances) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Cytotoxics (Oncology Drug Substances) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Cytotoxics (Oncology Drug Substances) Industry Development

    Chapter 3 Cytotoxics (Oncology Drug Substances)Industry Chain Analysis

    • 3.1 Cytotoxics (Oncology Drug Substances) Industry Chain

    • 3.2 Cytotoxics (Oncology Drug Substances) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Cytotoxics (Oncology Drug Substances) Market

    • 3.3 Cytotoxics (Oncology Drug Substances) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Cytotoxics (Oncology Drug Substances) Market

    Chapter 4 China Cytotoxics (Oncology Drug Substances) Market, by Type

    • 4.1 China Cytotoxics (Oncology Drug Substances) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Cytotoxics (Oncology Drug Substances) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Cytotoxics (Oncology Drug Substances) Production Volume and Growth Rate, by Type

      • 4.5.1 China Cytotoxics (Oncology Drug Substances) Production Volume and Growth Rate of Intravenous

      • 4.5.2 China Cytotoxics (Oncology Drug Substances) Production Volume and Growth Rate of Oral

    Chapter 5 China Cytotoxics (Oncology Drug Substances) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Cytotoxics (Oncology Drug Substances) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate, by Application

      • 5.5.1 China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate of Prostate Cancer

      • 5.5.2 China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate of Other

      • 5.5.3 China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate of Pancreatic Cancer

      • 5.5.4 China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate of Breast Cancer

      • 5.5.5 China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate of Lung Cancer

    Chapter 6 China Cytotoxics (Oncology Drug Substances) Market, by Region

    • 6.1 China Cytotoxics (Oncology Drug Substances) Production Volume and Production Value, by Region

    • 6.2 China Cytotoxics (Oncology Drug Substances) Sales Volume and Sales Value, by Region

    Chapter 7 North China Cytotoxics (Oncology Drug Substances) Market Analysis

    • 7.1 North China Cytotoxics (Oncology Drug Substances) Market, by Type

    • 7.2 North China Cytotoxics (Oncology Drug Substances) Market, by Application

    Chapter 8 Central China Cytotoxics (Oncology Drug Substances) Market Analysis

    • 8.1 Central China Cytotoxics (Oncology Drug Substances) Market, by Type

    • 8.2 Central China Cytotoxics (Oncology Drug Substances) Market, by Application

    Chapter 9 South China Cytotoxics (Oncology Drug Substances) Market Analysis

    • 9.1 South China Cytotoxics (Oncology Drug Substances) Market, by Type

    • 9.2 South China Cytotoxics (Oncology Drug Substances) Market, by Application

    Chapter 10 East China Cytotoxics (Oncology Drug Substances) Market Analysis

    • 10.1 East China Cytotoxics (Oncology Drug Substances) Market, by Type

    • 10.2 East China Cytotoxics (Oncology Drug Substances) Market, by Application

    Chapter 11 Northeast China Cytotoxics (Oncology Drug Substances) Market Analysis

    • 11.1 Northeast China Cytotoxics (Oncology Drug Substances) Market, by Type

    • 11.2 Northeast China Cytotoxics (Oncology Drug Substances) Market, by Application

    Chapter 12 Southwest China Cytotoxics (Oncology Drug Substances) Market Analysis

    • 12.1 Southwest China Cytotoxics (Oncology Drug Substances) Market, by Type

    • 12.2 Southwest China Cytotoxics (Oncology Drug Substances) Market, by Application

    Chapter 13 Northwest China Cytotoxics (Oncology Drug Substances) Market Analysis

    • 13.1 Northwest China Cytotoxics (Oncology Drug Substances) Market, by Type

    • 13.2 Northwest China Cytotoxics (Oncology Drug Substances) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 F Hoffmann-La Roche AG

        • 14.1.1 F Hoffmann-La Roche AG Company Profile

        • 14.1.2 F Hoffmann-La Roche AG Cytotoxics (Oncology Drug Substances) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Johnson & Johnson

        • 14.2.1 Johnson & Johnson Company Profile

        • 14.2.2 Johnson & Johnson Cytotoxics (Oncology Drug Substances) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Pfizer Inc

        • 14.3.1 Pfizer Inc Company Profile

        • 14.3.2 Pfizer Inc Cytotoxics (Oncology Drug Substances) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 GlaxoSmithKline plc

        • 14.4.1 GlaxoSmithKline plc Company Profile

        • 14.4.2 GlaxoSmithKline plc Cytotoxics (Oncology Drug Substances) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 AbbVie, Inc

        • 14.5.1 AbbVie, Inc Company Profile

        • 14.5.2 AbbVie, Inc Cytotoxics (Oncology Drug Substances) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Novartis AG

        • 14.6.1 Novartis AG Company Profile

        • 14.6.2 Novartis AG Cytotoxics (Oncology Drug Substances) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Sanofi

        • 14.7.1 Sanofi Company Profile

        • 14.7.2 Sanofi Cytotoxics (Oncology Drug Substances) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Baxter

        • 14.8.1 Baxter Company Profile

        • 14.8.2 Baxter Cytotoxics (Oncology Drug Substances) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Merck & Co Inc

        • 14.9.1 Merck & Co Inc Company Profile

        • 14.9.2 Merck & Co Inc Cytotoxics (Oncology Drug Substances) Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Cytotoxics (Oncology Drug Substances) Industry Research Conclusions

    • 15.2 Cytotoxics (Oncology Drug Substances) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Cytotoxics (Oncology Drug Substances) Industry Market Size (2018-2029)

    • Figure China Cytotoxics (Oncology Drug Substances) Production Volume, Production Value and Growth Rate of Intravenous (2018-2029)

    • Figure China Cytotoxics (Oncology Drug Substances) Production Volume, Production Value and Growth Rate of Oral (2018-2029)

    • Figure China Cytotoxics (Oncology Drug Substances) Sales Volume, Sales Value and Growth Rate of Prostate Cancer (2018-2029)

    • Figure China Cytotoxics (Oncology Drug Substances) Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China Cytotoxics (Oncology Drug Substances) Sales Volume, Sales Value and Growth Rate of Pancreatic Cancer (2018-2029)

    • Figure China Cytotoxics (Oncology Drug Substances) Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

    • Figure China Cytotoxics (Oncology Drug Substances) Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

    • Figure North China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate from 2018-2029

    • Figure Central China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate from 2018-2029

    • Figure South China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate from 2018-2029

    • Figure East China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate from 2018-2029

    • Figure Cytotoxics (Oncology Drug Substances) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Cytotoxics (Oncology Drug Substances) Market Share by Type in 2018

    • Figure China Cytotoxics (Oncology Drug Substances) Market Share by Type in 2023

    • Figure China Cytotoxics (Oncology Drug Substances) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Cytotoxics (Oncology Drug Substances) Production Volume and Growth Rate of Intravenous (2018-2023)

    • Figure China Cytotoxics (Oncology Drug Substances) Production Volume and Growth Rate of Oral (2018-2023)

    • Figure China Cytotoxics (Oncology Drug Substances) Market Share by Application in 2018

    • Figure China Cytotoxics (Oncology Drug Substances) Market Share by Application in 2023

    • Figure China Cytotoxics (Oncology Drug Substances) Total Market Size and Growth Rate from Consumption End

    • Figure China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate of Prostate Cancer (2018-2023)

    • Figure China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate of Other (2018-2023)

    • Figure China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate of Pancreatic Cancer (2018-2023)

    • Figure China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate of Breast Cancer (2018-2023)

    • Figure China Cytotoxics (Oncology Drug Substances) Market Size and Growth Rate of Lung Cancer (2018-2023)

    • Table China Cytotoxics (Oncology Drug Substances) Production Volume by Region (2018-2023)

    • Table China Cytotoxics (Oncology Drug Substances) Production Volume Share by Region (2018-2023)

    • Figure China Cytotoxics (Oncology Drug Substances) Production Volume Share by Region (2018-2023)

    • Table China Cytotoxics (Oncology Drug Substances) Production Value by Region (2018-2023)

    • Table China Cytotoxics (Oncology Drug Substances) Production Value Share by Region (2018-2023)

    • Figure China Cytotoxics (Oncology Drug Substances) Production Value Share by Region (2018-2023)

    • Table China Cytotoxics (Oncology Drug Substances) Sales Volume by Region (2018-2023)

    • Table China Cytotoxics (Oncology Drug Substances) Sales Volume Share by Region (2018-2023)

    • Figure China Cytotoxics (Oncology Drug Substances) Sales Volume Share by Region (2018-2023)

    • Table China Cytotoxics (Oncology Drug Substances) Sales Value by Region (2018-2023)

    • Table China Cytotoxics (Oncology Drug Substances) Sales Value Share by Region (2018-2023)

    • Figure China Cytotoxics (Oncology Drug Substances) Sales Value Share by Region (2018-2023)

    • Table North China Cytotoxics (Oncology Drug Substances) Production Volume by Type (2018-2023)

    • Table North China Cytotoxics (Oncology Drug Substances) Production Volume Share by Type (2018-2023)

    • Figure North China Cytotoxics (Oncology Drug Substances) Production Volume Share by Type (2018-2023)

    • Table North China Cytotoxics (Oncology Drug Substances) Sales Volume by Application (2018-2023)

    • Table North China Cytotoxics (Oncology Drug Substances) Sales Volume Share by Application (2018-2023)

    • Figure North China Cytotoxics (Oncology Drug Substances) Sales Volume Share by Application (2018-2023)

    • Table Central China Cytotoxics (Oncology Drug Substances) Production Volume by Type (2018-2023)

    • Table Central China Cytotoxics (Oncology Drug Substances) Production Volume Share by Type (2018-2023)

    • Figure Central China Cytotoxics (Oncology Drug Substances) Production Volume Share by Type (2018-2023)

    • Table Central China Cytotoxics (Oncology Drug Substances) Sales Volume by Application (2018-2023)

    • Table Central China Cytotoxics (Oncology Drug Substances) Sales Volume Share by Application (2018-2023)

    • Figure Central China Cytotoxics (Oncology Drug Substances) Sales Volume Share by Application (2018-2023)

    • Table South China Cytotoxics (Oncology Drug Substances) Production Volume by Type (2018-2023)

    • Table South China Cytotoxics (Oncology Drug Substances) Production Volume Share by Type (2018-2023)

    • Figure South China Cytotoxics (Oncology Drug Substances) Production Volume Share by Type (2018-2023)

    • Table South China Cytotoxics (Oncology Drug Substances) Sales Volume by Application (2018-2023)

    • Table South China Cytotoxics (Oncology Drug Substances) Sales Volume Share by Application (2018-2023)

    • Figure South China Cytotoxics (Oncology Drug Substances) Sales Volume Share by Application (2018-2023)

    • Table East China Cytotoxics (Oncology Drug Substances) Production Volume by Type (2018-2023)

    • Table East China Cytotoxics (Oncology Drug Substances) Production Volume Share by Type (2018-2023)

    • Figure East China Cytotoxics (Oncology Drug Substances) Production Volume Share by Type (2018-2023)

    • Table East China Cytotoxics (Oncology Drug Substances) Sales Volume by Application (2018-2023)

    • Table East China Cytotoxics (Oncology Drug Substances) Sales Volume Share by Application (2018-2023)

    • Figure East China Cytotoxics (Oncology Drug Substances) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Cytotoxics (Oncology Drug Substances) Production Volume by Type (2018-2023)

    • Table Northeast China Cytotoxics (Oncology Drug Substances) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Cytotoxics (Oncology Drug Substances) Production Volume Share by Type (2018-2023)

    • Table Northeast China Cytotoxics (Oncology Drug Substances) Sales Volume by Application (2018-2023)

    • Table Northeast China Cytotoxics (Oncology Drug Substances) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Cytotoxics (Oncology Drug Substances) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Cytotoxics (Oncology Drug Substances) Production Volume by Type (2018-2023)

    • Table Southwest China Cytotoxics (Oncology Drug Substances) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Cytotoxics (Oncology Drug Substances) Production Volume Share by Type (2018-2023)

    • Table Southwest China Cytotoxics (Oncology Drug Substances) Sales Volume by Application (2018-2023)

    • Table Southwest China Cytotoxics (Oncology Drug Substances) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Cytotoxics (Oncology Drug Substances) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Cytotoxics (Oncology Drug Substances) Production Volume by Type (2018-2023)

    • Table Northwest China Cytotoxics (Oncology Drug Substances) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Cytotoxics (Oncology Drug Substances) Production Volume Share by Type (2018-2023)

    • Table Northwest China Cytotoxics (Oncology Drug Substances) Sales Volume by Application (2018-2023)

    • Table Northwest China Cytotoxics (Oncology Drug Substances) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Cytotoxics (Oncology Drug Substances) Sales Volume Share by Application (2018-2023)

    • Table F Hoffmann-La Roche AG Company Profile

    • Table F Hoffmann-La Roche AG Cytotoxics (Oncology Drug Substances) Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Cytotoxics (Oncology Drug Substances) Revenue, Price and Gross (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Cytotoxics (Oncology Drug Substances) Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline plc Company Profile

    • Table GlaxoSmithKline plc Cytotoxics (Oncology Drug Substances) Revenue, Price and Gross (2018-2023)

    • Table AbbVie, Inc Company Profile

    • Table AbbVie, Inc Cytotoxics (Oncology Drug Substances) Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Cytotoxics (Oncology Drug Substances) Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Cytotoxics (Oncology Drug Substances) Revenue, Price and Gross (2018-2023)

    • Table Baxter Company Profile

    • Table Baxter Cytotoxics (Oncology Drug Substances) Revenue, Price and Gross (2018-2023)

    • Table Merck & Co Inc Company Profile

    • Table Merck & Co Inc Cytotoxics (Oncology Drug Substances) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US